Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant – Medical Xpress
OncLive |
Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant
Medical Xpress Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial in these patients of one … Dr. Davids on Checkpoint Blockade Inhibition in Hematologic … |
